Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
February 4, 2022
Novel systemic treatment approaches for metastatic pancreatic cancer
Klara Dorman, Volker Heinemann, Sebastian Kobold, et al.
Anti-Cancer Drugs
|
October 7, 2022
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Klara Dorman, Anton Burkhard-Meier, Dorit Di Gioia, et al.
Anticancer Research
|
March 28, 2023
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman
Klara Dorman, Danmei Zhang, Wolfgang G Kunz, et al.
Cancers
|
August 29, 2024
Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML
Alessia Fraccaroli, Elena Stauffer, Sarah Haebe, et al.
Cells
|
March 27, 2026
Distinct Mutation Signatures in Peripheral Blood Mitochondrial DNA from Liquid Biopsy Reveal Insights into Pancreatic Cancer
Hannah Randeu, Abel Bronkhorst, Angela Oberhofer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2024
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial
Danmei Zhang, C Benedikt Westphalen, Michael Quante, et al.
Oncology Research and Treatment
|
December 18, 2022
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study
Danmei Zhang, Stephan Kruger, Karoline Schirle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2024
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C Benedikt Westphalen, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2022
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
Klara Dorman, Miriam Gerckens, Stephan Kruger, et al.
The Lancet. Gastroenterology & Hepatology
|
August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
Klara Dorman, Stefan Boeck, Karel Caca, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
February 4, 2022
Novel systemic treatment approaches for metastatic pancreatic cancer
Klara Dorman, Volker Heinemann, Sebastian Kobold, et al.
Anti-Cancer Drugs
|
October 7, 2022
Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
Klara Dorman, Anton Burkhard-Meier, Dorit Di Gioia, et al.
Anticancer Research
|
March 28, 2023
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman
Klara Dorman, Danmei Zhang, Wolfgang G Kunz, et al.
Cancers
|
August 29, 2024
Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML
Alessia Fraccaroli, Elena Stauffer, Sarah Haebe, et al.
Cells
|
March 27, 2026
Distinct Mutation Signatures in Peripheral Blood Mitochondrial DNA from Liquid Biopsy Reveal Insights into Pancreatic Cancer
Hannah Randeu, Abel Bronkhorst, Angela Oberhofer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2024
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial
Danmei Zhang, C Benedikt Westphalen, Michael Quante, et al.
Oncology Research and Treatment
|
December 18, 2022
Clinical Impact of Structured Post-Operative Surveillance in Resected Pancreatic Adenocarcinoma: Results from a Retrospective Cohort Study
Danmei Zhang, Stephan Kruger, Karoline Schirle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2024
Unresectable biliary tract cancer: Current and future systemic therapy
Danmei Zhang, Klara Dorman, C Benedikt Westphalen, et al.
Journal of Cancer Research and Clinical Oncology
|
June 23, 2022
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers
Klara Dorman, Miriam Gerckens, Stephan Kruger, et al.
The Lancet. Gastroenterology & Hepatology
|
August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
Klara Dorman, Stefan Boeck, Karel Caca, et al.
Page
of 2